Infection Control Policy

Cystic Fibrosis Research, Inc. (CFRI) is committed to the safety and well‐being of all people attending CFRI sponsored activities. CFRI promotes stringent cross infection guidelines in maintaining high standards to minimize the risk of cross infection at CFRI events and elsewhere as fitting.

Cystic fibrosis (CF) infection control and prevention guidelines at CFRI may differ from those at your CF center; please consult your CF care providers for the most up to date guidelines at your care center.

CFRI has guidelines in its Infection Control Policy which preclude individuals culturing specific pathogens from attending CFRI events. These include:

  • Never had a confirmed positive culture on an organism belonging to or related to Burkholderia cepacia complex (;
  • Have not cultured MRSA within the past 12 months;
  • Have not had a positive culture for Nontuberculous mycobacteria (NTM) in the past 12 months; and
  • Do not currently culture positive for any pandrug resistant (PDR) bacteria (bacterial isolates non‐susceptible to all agents in all antimicrobial categories) or extensively drug resistant (XDR) bacteria that remain susceptible to only one category of antimicrobials (does not apply to XDR isolates remaining susceptible to two or more categories of antimicrobials).

While the guidelines in the policy document are designed to reduce risks of infection, attendees should be aware that there remains the possibility that persons attending a CFRI-sponsored event carry pathogens that may be harmful to people with CF that could be transmitted unknowingly or inadvertently to others in attendance.

Because CFRI cannot guarantee an environment risk free of transmissible pathogens, each attendee must make her/his own evaluation of the benefits and risks in deciding to attend. Assistance in making such decisions may best be obtained from the potential attendee’s physician.

Download Infection Control Policy Document